{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:06:05Z","timestamp":1790877965878,"version":"4.1.0"},"reference-count":18,"publisher":"Department of Medicine, Warren Alpert Medical School at Brown University","issue":"4","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.56305\/001c.171947","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:37:25Z","timestamp":1790876245000},"source":"Crossref","is-referenced-by-count":0,"title":["Updates in Hospital Medicine: Oncology"],"prefix":"10.56305","volume":"5","author":[{"given":"Andrew C.","family":"Lyu","sequence":"first","affiliation":[{"name":"MaineHealth Maine Medical Center","department":["Department of Medicine, Division of Hospital Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Coleman","sequence":"additional","affiliation":[{"name":"MaineHealth Maine Medical Center","department":["Department of Medicine, Division of Hospital Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley B.","family":"Gordon","sequence":"additional","affiliation":[{"name":"MaineHealth Maine Medical Center","department":["Department of Medicine, Division of Hospital Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"35509","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"41","key":"ref1","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"A. R. Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"14","key":"ref2","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"F. I. Mulder","year":"2021","journal-title":"Blood"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer \u2013 a cohort study using linked United Kingdom databases","volume":"49","author":"A. J. Walker","year":"2013","journal-title":"Eur J Cancer"},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"A. A. Khorana","year":"2007","journal-title":"Cancer"},{"issue":"22","key":"ref5","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1182\/blood.2024025362","article-title":"Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study","volume":"144","author":"C. Englisch","year":"2024","journal-title":"Blood"},{"issue":"14","key":"ref6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"F. Couturaud","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"e0186674","DOI":"10.1371\/journal.pone.0186674","article-title":"Splenomegaly - diagnostic validity, work-up, and underlying causes","volume":"12","author":"E. Curovic Rotbain","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1148\/radiol.2015150887","article-title":"Spleen size is significantly influenced by body height and sex: establishment of normal values for spleen size at US with a cohort of 1200 healthy individuals","volume":"279","author":"K. U. Chow","year":"2016","journal-title":"Radiology"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamaoncol.2025.5934","article-title":"Incidentally detected splenomegaly and risk of hematologic cancer and liver disease","volume":"12","author":"A. R. Juhl","year":"2026","journal-title":"JAMA Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1200\/JCO.2024.42.16_suppl.11057","article-title":"Overlapping and non-overlapping indications for checkpoint inhibitors in the US","volume":"42","author":"J. Paul","year":"2024","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"e200423","DOI":"10.1001\/jamanetworkopen.2020.0423","article-title":"Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs","volume":"3","author":"A. Haslam","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"ref12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/onco.13740","article-title":"Temporal trends and outcomes among patients admitted for immune-related adverse events: a single-center retrospective cohort study from 2011 to 2018","volume":"26","author":"G. E. Molina","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jamaoncol.2025.4543","article-title":"Immune checkpoint inhibitor\u2013associated cardiovascular toxic effects: International Cardio-Oncology Society position statement","volume":"12","author":"J. Herrmann","year":"2026","journal-title":"JAMA Oncol"},{"issue":"10","key":"ref14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","article-title":"Immune checkpoint inhibitor-induced cardiotoxicity: a systematic review and meta-analysis","volume":"10","author":"D. L. Nielsen","year":"2024","journal-title":"JAMA Oncol"},{"issue":"12","key":"ref15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"D. Y. Wang","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/joim.20028","article-title":"Association among major adverse cardiovascular events with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"297","author":"H. Li","year":"2025","journal-title":"J Intern Med"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"J. Herrmann","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","first-page":"e001887","DOI":"10.1136\/jitc-2020-001887","article-title":"Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis","volume":"8","author":"J. Cautela","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Journal of Brown Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bhm.scholasticahq.com\/article\/171947-updates-in-hospital-medicine-oncology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:37:26Z","timestamp":1790876246000},"score":1,"resource":{"primary":{"URL":"https:\/\/bhm.scholasticahq.com\/article\/171947-updates-in-hospital-medicine-oncology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.56305\/001c.171947","relation":{},"ISSN":["2994-5593"],"issn-type":[{"value":"2994-5593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}